UPC (Universe Pharmaceuticals) Total Stockholders Equity: $56.13 Mil (As of Sep. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

UPC Universe Pharmaceuticals Inc UPC
62 GF Score
Price $4.18
GF Value $5.16
Valuation Modestly Undervalued
! 7 Warning Signs
View Full Analysis

What is Universe Pharmaceuticals Total Stockholders Equity?

Universe Pharmaceuticals UPC +1.62% 62 Total Stockholders Equity is $56.13 Mil as of Sep. 2025. GuruFocus rates UPC with a GF Score™ of 62/100 and a GF Value™ of $5.16 (Modestly Undervalued). The stock has 7 warning signs investors should review.

Universe Pharmaceuticals's Total Stockholders Equity for the quarter that ended in Sep. 2025 was $56.13 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Universe Pharmaceuticals's Book Value per Share for the quarter that ended in Sep. 2025 was $99.70. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Universe Pharmaceuticals's Debt-to-Equity for the quarter that ended in Sep. 2025 was 0.16.

Universe Pharmaceuticals  (NAS:UPC) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Universe Pharmaceuticals's Book Value per Share for the quarter that ended in Sep. 2025 is

Book Value per Share=(Total Stockholders Equity-Preferred Stock)/Shares Outstanding (EOP)
=(56.13-0)/0.563
=99.70

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Universe Pharmaceuticals's Debt-to-Equity for the quarter that ended in Sep. 2025 is

Debt-to-Equity=Total Debt / Total Stockholders Equity
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Stockholders Equity
=(9.257 + 0) / 56.13
=0.16

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Universe Pharmaceuticals Total Stockholders Equity Related Terms

Universe Pharmaceuticals Total Stockholders Equity Historical Data

* Premium members only.

The historical data trend for Universe Pharmaceuticals's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Universe Pharmaceuticals Total Stockholders Equity Chart

Universe Pharmaceuticals Annual Data
Trend Sep18 Sep19 Sep20 Sep21 Sep22 Sep23 Sep24 Sep25
Total Stockholders Equity
Get a 7-Day Free Trial 58.93 46.44 27.97 45.50 56.13

Universe Pharmaceuticals Semi-Annual Data
Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25
Total Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 27.97 26.74 45.50 55.19 56.13
UPC
62GF Score
Universe Pharmaceuticals Inc UPC
Total Stockholders Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a Total Stockholders Equity of $56.13 Mil mean?
Universe Pharmaceuticals (UPC) has a Total Stockholders Equity of $56.13 Mil as of Sep. 2025. The total amount of shareholder's equity as recorded on a company's balance sheet. View historical data for Universe Pharmaceuticals and its competitors.
Is Universe Pharmaceuticals' Total Stockholders Equity too high?
Universe Pharmaceuticals' current Total Stockholders Equity is $56.13 Mil. Overall, Universe Pharmaceuticals has a GF Score™ of 62/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Universe Pharmaceuticals' Total Stockholders Equity compare to CPMD and SHPH?
Universe Pharmaceuticals' Total Stockholders Equity of $56.13 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Stockholders Equity for a Drug Manufacturers company?
A good Total Stockholders Equity depends on the Drug Manufacturers industry context. However, Total Stockholders Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Stockholders Equity mean?
A high Total Stockholders Equity can signal that a stock is expensive relative to its fundamentals. The total amount of shareholder's equity as recorded on a company's balance sheet. View historical data for Universe Pharmaceuticals and its competitors. Universe Pharmaceuticals's current Total Stockholders Equity is $56.13 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Universe Pharmaceuticals stock overvalued right now?
Based on GuruFocus' analysis, Universe Pharmaceuticals (UPC) is currently considered Modestly Undervalued. The stock's GF Value™ is $5.16, compared to a current price of $4.18 — trading 19% below its estimated fair value. The current Total Stockholders Equity is $56.13 Mil. Universe Pharmaceuticals' overall GF Score™ is 62/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Stockholders Equity calculated?
Total Stockholders Equity is calculated from a company's financial statements. For Universe Pharmaceuticals (UPC), the current Total Stockholders Equity is $56.13 Mil as of Sep. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Universe Pharmaceuticals (UPC) Overvalued in 2026?

Based on GuruFocus' analysis, Universe Pharmaceuticals stock appears to be undervalued. The current stock price of $4.18 is trading 19% below its estimated GF Value™ of $5.16. GuruFocus considers Universe Pharmaceuticals to be Modestly Undervalued.

Key valuation signals for UPC:

  • Total Stockholders Equity: $56.13 Mil
  • GF Value™: $5.16 vs. price of $4.18 (19% below fair value)
  • GF Score™: 62/100 with 7 warning signs

No single metric tells the full story. See the UPC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Universe Pharmaceuticals Business Description

Address 265 Jingjiu Avenue, Jinggangshan Economic & Technological Development Zone, Jiangxi, Ji’an, CHN, 343100
Universe Pharmaceuticals Inc is a pharmaceutical company specializing in the manufacturing, marketing, sales and distribution of traditional Chinese medicine derivatives products targeting the elderly with the goal of addressing their physical conditions in the ageing process and promoting their general well-being. The company also sells biomedical drugs, medical instruments, Traditional Chinese Medicine Pieces, and dietary supplements manufactured by third-party pharmaceutical companies. Its products are under two categories namely treatment and relief for common chronic health conditions in the elderly designed to achieve physical wellness and longevity (Chronic Condition Treatments), and cold and flu medications.
62GF Score

Get the complete analysis for UPC

Total Stockholders Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$4.18
Price
$5.16
GF Value